Resmed Inc. buy Citigroup Inc.
Start price
05.03.25
/
50%
€205.00
Target price
05.03.26
-
Performance (%)
6.83%
End price
06.03.26
€219.00
Summary
This prediction ended on 06.03.26 with a price of €219.00. With a performance of 6.83%, the BUY prediction by Citigroup_Inc_ for Resmed Inc. closed with a slight gain. Citigroup_Inc_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.412% | 0.412% | 3.803% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten